Passage Bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Passage Bio and other ETFs, options, and stocks.

About PASG

Passage Bio, Inc. operates as a genetic medicines company. It focuses on development of therapies for central nervous system disorders. 

CEO
William Chou
CEOWilliam Chou
Employees
24
Employees24
Headquarters
Philadelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded
2017
Founded2017
Employees
24
Employees24

PASG Key Statistics

Market cap
15.45M
Market cap15.45M
Price-Earnings ratio
-0.41
Price-Earnings ratio-0.41
Dividend yield
Dividend yield
Average volume
57.80K
Average volume57.80K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$20.00
52 Week high$20.00
52 Week low
$3.29
52 Week low$3.29

Stock Snapshot

With a market cap of 15.45M, Passage Bio(PASG) trades at $4.81. The stock has a price-to-earnings ratio of -0.41.

On 2026-07-21, Passage Bio(PASG) shares started trading at —, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 57.8K.

The stock's 52-week range extends from a low of $3.29 to a high of $20.00.

The stock's 52-week range extends from a low of $3.29 to a high of $20.00.

People also own

Based on the portfolios of people who own PASG. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.